NERV logo

NERV
Minerva Neurosciences Inc

9,598
Mkt Cap
$228.49M
Volume
188,601.00
52W High
$12.46
52W Low
$1.15
PE Ratio
-0.20
NERV Fundamentals
Price
$5.28
Prev Close
$5.60
Open
$5.46
50D MA
$6.09
Beta
0.80
Avg. Volume
424,250.57
EPS (Annual)
-$34.67
P/B
-1.62
Rev/Employee
$0.00
$16.58
Loading...
Loading...
News
all
press releases
Short Interest in Minerva Neurosciences, Inc (NASDAQ:NERV) Grows By 27.8%
Minerva Neurosciences, Inc (NASDAQ:NERV - Get Free Report) saw a significant growth in short interest in March. As of March 13th, there was short interest totaling 559,530 shares, a growth of 27.8...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Minerva Neurosciences Touts Roluperidone Data, FDA-Aligned Trial Plan for Schizophrenia Symptoms
Minerva Neurosciences (NASDAQ:NERV) provided an update on its development program for roluperidone, which the company described as a potential first treatment option aimed at the negative symptoms of...
MarketBeat·15d ago
News Placeholder
HC Wainwright Has Bullish Forecast for NERV Q1 Earnings
Minerva Neurosciences, Inc (NASDAQ:NERV - Free Report) - Equities research analysts at HC Wainwright increased their Q1 2026 earnings per share (EPS) estimates for shares of Minerva Neurosciences in...
MarketBeat·20d ago
News Placeholder
What is HC Wainwright's Forecast for NERV Q1 Earnings?
Minerva Neurosciences, Inc (NASDAQ:NERV - Free Report) - Investment analysts at HC Wainwright issued their Q1 2027 earnings estimates for shares of Minerva Neurosciences in a research note issued to...
MarketBeat·23d ago
News Placeholder
Minerva Neurosciences (NASDAQ:NERV) Issues Quarterly Earnings Results
Minerva Neurosciences (NASDAQ:NERV - Get Free Report) released its quarterly earnings data on Wednesday. The biopharmaceutical company reported $0.64 earnings per share (EPS) for the quarter, topping...
MarketBeat·25d ago
News Placeholder
Minerva Neurosciences (NASDAQ:NERV) Upgraded to Hold at Wall Street Zen
Wall Street Zen upgraded shares of Minerva Neurosciences from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·1mo ago
News Placeholder
Minerva Neurosciences (NASDAQ:NERV) Shares Pass Above 50 Day Moving Average - Here's What Happened
Minerva Neurosciences (NASDAQ:NERV) Shares Pass Above Fifty Day Moving Average - What's Next...
MarketBeat·1mo ago
News Placeholder
Minerva Neurosciences (NERV) to Release Earnings on Tuesday
Minerva Neurosciences (NASDAQ:NERV) will be releasing its Q4 2025 earnings before the market opens on Tuesday, February 24. (View Earnings Report at...
MarketBeat·2mo ago
News Placeholder
Minerva Neurosciences, Inc (NASDAQ:NERV) Short Interest Update
Minerva Neurosciences, Inc (NASDAQ:NERV - Get Free Report) was the recipient of a significant growth in short interest during the month of January. As of January 30th, there was short interest...
MarketBeat·2mo ago
News Placeholder
Minerva Neurosciences Spotlights Roluperidone, Lays Out Confirmatory Phase 3 Timeline for Schizophrenia
Minerva Neurosciences (NASDAQ:NERV) hosted a virtual key opinion leader (KOL) event focused on its development candidate roluperidone for negative symptoms in schizophrenia, outlining the clinical...
MarketBeat·2mo ago
<
1
2
...
>

Latest NERV News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.